Invida appoints senior executives
This article was originally published in Scrip
The Singapore-based Invida Group has appointed Anne Bell as chief financial officer and Christopher Tay as chief administrative officer. Ms Bell has previously worked for AstraZeneca as its Asia-Pacific regional finance director, based in Singapore, and as programme director, finance, at the firm's UK headquarters. Mr Tay qualified as a solicitor in Singapore and has previously worked for Singapore Airlines and Hewlett Packard.
You may also be interested in...
Join us for a quick audio roundup of major developments in the international biopharma industry over the past week, as covered by Scrip's global team.
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.